PAM
VCNX

Panagora Asset Management’s Vaccinex, Inc. Common Stock VCNX Stock Holding History

Panagora Asset Management’s Portfolio VCNX Stock Details VCNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2
Closed -$1K – 2441
2021
Q2 		$1K Hold
2
– – ﹤0.01% 2723
2021
Q1 		$1K Hold
2
– – ﹤0.01% 2795
2020
Q4 		$1K Buy
+2
New +$837 ﹤0.01% 2758
2019
Q4 		– Sell
-1
Closed -$1K – 2599
2019
Q3 		$1K Sell
1
-12
-92% -$13.5K ﹤0.01% 2425
2019
Q2 		$15K Sell
13
-1
-7% -$1.33K ﹤0.01% 2335
2019
Q1 		$15K Buy
14
+7
+100% +$6.72K ﹤0.01% 2322
2018
Q4 		$6K Buy
+7
New +$8.55K ﹤0.01% 2364

Other funds holding VCNX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
N
Natixis Paris, France $24.8B AUM 35.22% 1-Year Est. Return
OC
Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Panagora Asset Management's VCNX Position: Q3 2021 in Review

Panagora Asset Management sold out of Vaccinex, Inc. Common Stock (VCNX) in Q3 2021, closing a stake of 2 shares — an estimated $1K sold.

Panagora Asset Management first reported a position in VCNX in Q4 2018 and held it in 7 quarters. The position peaked at $15K in Q2 2019. 21 funds tracked by Wall St. Rank hold VCNX as of Q3 2021.

  • Panagora Asset Management reported no remaining Vaccinex, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Panagora Asset Management sold 2 Vaccinex, Inc. Common Stock shares in Q3 2021, an estimated $1K.
  • Panagora Asset Management first reported a position in Vaccinex, Inc. Common Stock in Q4 2018 and held it in 7 quarters.
  • Panagora Asset Management's Vaccinex, Inc. Common Stock position peaked at $15K in Q2 2019.
  • 21 funds tracked by Wall St. Rank held Vaccinex, Inc. Common Stock as of Q3 2021.

Based on Panagora Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.